1 "Acute Lymphocytic Leukemia" clinical trial found.

• 

  Managed Access Program (MAP) to provide access to CTL019 for acute lymphoblastic leukemia (ALL) or diffuse large b-cell lymphoma (DLBCL ...

  The purpose of this Treatment Plan is to allow access to tisagenlecleucel (CTL019) for eligible patients diagnosed with acute lymphoblastic ...

  Exact  Phase N/A Stephen Schuster